Engel et al., "Tricyclic Compounds as Selective Muscarinic Receptor Antagonists. 3. Structure-Activity Relationships in a Series of Cardioselective (M.sub.2) Antimuscarinics," J. Med. Chem., 32:1718-1724 (1989). |
Karton et al., "Synthesis and Biological Activity of Some Methoctramine--Related Tetraamines Bearing a 11-Acetyl-5,11-dihydro-6H-pyrido�2,3-b!�1,4!benzodiazepin-6-one Moiety as Antimuscarinics: A Second Generation of Highly Selective M.sub.2 Muscarinic Receptor Antagonists," J. Med. Chem., 34:2133-2145 (1991). |
Melchiorre et al., "Functionalized Congener Approach to Muscarinic Antagonists: Analogues of Pirenzepine," J. Med. Chem., 36:3734-3737 (1993). |
Doods et al., "Therapeutic Potential of CNS-Active M.sub.2 Antagonists Novel Structures and Pharmacology," Life Sciences, 52:497-503 (1993). |
Aubert, I., et al., "Characterization and Autoradiographic Distribution of �.sup.3 H!AF-DX 384 Binding to Putative Muscarinic M.sub.2 Receptors in the Rat Brain," Eur. J. Pharmacol. 217(2/3):173-184 (Jul. 7, 1992). |
Billard, W., et al., "Characterization of the Binding of .sup.3 H-SCH 23390, A Selective D-1 Receptor Antagonist Ligand, In Rat Striatum," Life Sci. 35(18):1885-1893 (1984). |
Bonner, T.I., "The Molecular Basis of Muscarinic Receptor Diversity," TINS 12(4):148-151 (1989). |
Buckley, N.J., et al., "Localization of a Family of Muscarinic Receptor mRNAs in Rat Brain," J. Neurosci. 8(12):4646-4652 (Dec. 1989). |
Collerton, D., "Cholinergic Function and Intellectual Decline in Alzheimer's Disease," Neurosci. 19(1):1-28 (1986). |
Dawson, V.L., et al., "Hippocampal Muscarinic Supersensitivity After AF64A Medial Septal Lesion Excludes M.sub.1 Receptors," Brain Res. Bull. 25:311-317 (Aug. 1990). |
Dawson, V.L., et al., "Alteration in Cortical Muscarinic Receptors Following Cholinotoxin (AF64A) Lesion of the Rat Nucleus Basalis magnocellularis," Neurobiol. Aging 13(1):25-32 (1991). |
Engel, G., et al., "Evidence for Common Pharmacological Properties of �.sup.3 H!5-Hydroxytryptamine Binding Sites, Presynaptic 5-Hydroxytryptamine Autoreceptors in CNS and Inhibitory Presynaptic 5-Hydroxytryptamine Receptors on Sympathetic Nerves," Naunyn Schmiedeberg's Arch. Pharmacol. 324(2):116-124 (1983). |
Engel, W.W., et al., "Tricyclic Compounds as Selective Muscarinic Receptor Antagonists, 3, Structure-Selectivity Relationships in a Series of Cardioselective (M.sub.2) Antimuscarinics," J. Med. Chem. 32(8):1718-1724 (1989). |
Entzeroth, M. and Mayer, N., "Labeling of Rat Heart Muscarinic Receptors Using the New M.sub.2 Selective Antagonist �.sup.3 H!AF-DX 384," Biochem. Pharmacol. 40(7):1674-1676 (1990). |
Glass, J.D., et al. "Benzyloxycarbonylarginine Nitrophenyl Ester Salts: 1-Hydroxybenzotriazole Catalyzed Acylations of Amines," Int. J. Peptide Protein Res. 12(2):75-80 (Aug. 1978). |
Goldman, J., et al. "Aging of the Brain: Dementia of the Alzheimer's Type," Principles of Neural Science, 3rd Edition, ed. Kandel et al., Chapter 62 (Part X), 974-983 (Elsevier New York 1991). |
Greenstein, J.P., et al., "Chemical Procedures for Synthesis of Peptides," Chemistry of the Amino Acids, vol. 2, 891-895, John Wiley and Sons, Inc. (New York 1961). |
Hammer, R., et al., "Binding Profile of a Novel Cardioselective Muscarine Receptor Antagonist, AF-DX 116, to Membranes of Peripheral Tissues and Brain in the Rat," Life Sci. 38(18):1653-1662 (1986). |
Hanisch, U.-K., et al., "Modulation of Hippocampal Acetylcholine Release: a Potent Central Action of Interleukin-2," J. Neurosci. 13(8):3368-3374 (Aug. 1993). |
Lapchak, P.A., et al. "Binding sites for �.sup.3 H!AF-DX 116 and Effect of AF-DX 116 on Endogenous Acetylcholine Release from Rat Brain Slices," Brain Res. 496(1/2):285-294 (Sep. 4, 1989). |
Lee, K.S., et al. "1,3-Dipropyl-8-Cyclopentylxanthine (DPCPX) Inhibition of �.sup.3 H!N-Ethylcarboxamidoadenosine (NECA) Binding Allows the Visualization of Putative Non-A1 Adenosine Receptors," Brain Res. 368(2):394-398 (Mar. 19, 1986). |
Liao, C.-F., et al. "Molecular Cloning and Expression of a Fifth Muscarinic Acetylcholine Receptor," J. Biol. Chem. 264(13):7328-7337 (May 5, 1989). |
Lott, R.S., et al., "Trimethylsilyl Iodide as a Peptide Deblocking Agent," J.C.S. Chem. Commun. 495-496 (1979). |
Lynch, C.J., et al., "Evidence for High and Low Affinity .alpha..sub.2 -Receptors," J. Biological Chem. 256(7):3298-3303 (Apr. 10, 1981). |
Martin, B.R., et al., "Relationship of the Biodisposition of the Stereoisomers of Nicotine in the Central Nervous System to Their Pharmacological Actions," J. Pharmacol. Exper. Therapeu. 226(1):157-163 (Jul. 1983). |
Mash, D.C., et al., "Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic Denervation," Science 288:1115-1117 (May 31, 1985). |
McCabe, R.T., et al., "Characterization of Benzodiazepine Receptors with Fluorescent Ligands," FASEB J. 4:2934-2940 (Aug. 1990). |
Michel, A.D., et al., "Direct Labeling of Rat M.sub.3 -Muscarinic Receptors by �.sup.3 H!4DAMP," Eur. J. Pharmacol. 166(3):459-466 (Aug. 3, 1989). |
Morris, R.G.M., "Spatial Localization Does Not Require Presence of Local Cues," Learning and Motivation 12:239-260 (1981). |
Pittel, Z., et al., "Distinct Muscarinic Receptor Subtypes Differentially Modulae Acetylcholine Release from Corticocerebral Synaptosomes," J. Neurochem. 55(2):665-672 (Aug. 1990). |
Quirion, R., et al., "Muscarinic Receptor Subtypes in Human Neurodegenerative Disorders: Focus on Alzheimer's Disease," TIPS Suppl. 80-84 (Dec. 1989). |
Sakahibara, S., et al., "A New Reagent for the p-Nitrophenylation of Carboxylic Acids," Bull. Chim. Soc. Jpn. 37(8):1231-1232 (Aug. 1964). |
Sloan, J.W., et al., "The Comparative Binding Characteristics of Nicotinic Ligands and Their Pharmacology," Pharmacol. Biochem. Behav. 30(1):255-267 (May 1988). |
Smith, G., "Animal Models for Alzheimer's Disease: Experimental Cholinergic Denervation," Brain Res. Rev. 13(2):103-118 (Apr./Jun. 1988). |
Spencer, D.G., et al., "Direct Autoradiographic Determination of M1 and M2 Muscarinic Acetylcholine Receptor Distribution in the Rat Brain: Relation to Cholinergic Nuclei and Projections," Brain Res. 380(1):59-68 (Aug. 13, 1986). |
Woodruff, G.N., et al., "Binding of �.sup.3 H!Sulpiride to Purified Rat Striatal Synaptic Membranes," Neuroscience 6(3):407-410 (1981). |
Yamamura, H.I., et al., (eds), In: Neurotransmitter Receptor Binding, 2nd ed., Raven Press, New York (1985). |